Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163783 · ClinicalTrials.gov registry record · Phase 1
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males
A Phase 1 study, sponsored by BeiGene.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04163783 is a Phase 1 study that has completed, run by BeiGene. The registered enrollment target is 6 participants.
The verdict
NCT04163783, a Phase 1 study, has completed, sponsored by BeiGene.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
Phase 1 study in healthy subjects to determine the effect of an 8-hour fast from food on the pharmacokinetics of \[14C\]-BGB-3111.
Interventions
- DRUG BGB-3111
- DRUG [14C]-BGB-3111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2017-04-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04163783
The ClinicalTrials.gov registry entry for NCT04163783 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BeiGene, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BGB-3111 is the first listed.
NCT04163783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04163783 about?
NCT04163783 is a clinical study titled "Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males". Phase 1 study in healthy subjects to determine the effect of an 8-hour fast from food on the pharmacokinetics of \[14C\]-BGB-3111.
What is the current status of trial NCT04163783?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-03-29. Estimated completion is 2017-04-18.
What interventions are being tested in trial NCT04163783?
The interventions under investigation include: BGB-3111 (DRUG), [14C]-BGB-3111 (DRUG).
Who is sponsoring clinical trial NCT04163783?
This trial is sponsored by BeiGene, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.